FDA Accelerated Approval Pathway in 2026: Requirements and Inspection Readiness
October 24, 2026
How does FDA accelerated approval affect drug development and GMP compliance? Explore clinical evidence requirements, confirmatory trials, postmarketing obligations, and inspection readiness. Learn how pharmaceutical manufacturers can reduce regulatory risks and prepare for FDA approval decisions in 2026.